English name：Pioglitazone Hydrochloride
3、Mechanism and clinical use:
Pioglitazone hydrochloride is a thiazolidinedione hypoglycemic agent and belongs to an insulin sensitizer. This product has no liver toxicity, and its safety is significantly better than troglitazone. Pioglitazone hydrochloride is absorbed orally, and it also has the effect of lowering blood lipids.
On September 2017, API Pioglitazone Hydrochloride was granted China GMP certificate.
On Dec .2020, API Pioglitazone Hydrochloride was granted “written confirmation for active substance exported to EU”.
4、Packaging size specification
Inner package: single-layer polyethylene bag and aluminum foil bag.
Outer package: Medicinal aluminum bottle
Packaging size: 14 kg/bottle